--- title: "花旗银行维持对安进(AMGN)的持有评级" description: "根据 TipRanks 的数据,Meacham 是一位四星分析师,平均回报率为 4.2%,成功率为 55.14%。Meacham 覆盖医疗保健行业,专注于如礼来公司(Eli Lilly & Co)、安进(Amgen)和 Vertex 制药等股票。除了花旗集团,安进在 10 月 10 日的报告中也获得了 Raymond James 的 Christopher Raymond 的持有评级。然而,在 1" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/260882086.md" published_at: "2025-10-13T10:55:50.000Z" --- # 花旗银行维持对安进(AMGN)的持有评级 > 根据 TipRanks 的数据,Meacham 是一位四星分析师,平均回报率为 4.2%,成功率为 55.14%。Meacham 覆盖医疗保健行业,专注于如礼来公司(Eli Lilly & Co)、安进(Amgen)和 Vertex 制药等股票。除了花旗集团,安进在 10 月 10 日的报告中也获得了 Raymond James 的 Christopher Raymond 的持有评级。然而,在 10 月 8 日,RBC Capital 对安进(NASDAQ: AMGN)维持了买入评级 根据 TipRanks 的数据,Meacham 是一位 4 星分析师,平均回报率为 4.2%,成功率为 55.14%。Meacham 覆盖医疗保健行业,关注的股票包括礼来公司、安进和 Vertex 制药。 除了花旗,安进在 10 月 10 日的报告中也获得了 Raymond James 的 Christopher Raymond 的持有评级。然而,在 10 月 8 日,RBC Capital 维持了对安进(NASDAQ: AMGN)的买入评级。 ### Related Stocks - [AMGN.US - 安进](https://longbridge.com/zh-CN/quote/AMGN.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update | Amgen executives discussed upcoming clinical milestones and data updates in their inflammation and immunology portfolio. | [Link](https://longbridge.com/zh-CN/news/275831709.md) | | Amgen receives EC approval for Uplizna in generalised myasthenia gravis | Amgen has received European Commission approval for Uplizna (inebilizumab) as an add-on treatment for adults with genera | [Link](https://longbridge.com/zh-CN/news/275884466.md) | | REG - Morgan Stanley&CoLLC Avadel Pharma plc - Rule 38.5_A - Avadel Pharmaceuticals plc | Morgan Stanley & Co. LLC disclosed dealings related to Avadel Pharmaceuticals plc under Rule 38.5(a) of the Irish Takeov | [Link](https://longbridge.com/zh-CN/news/275721511.md) | | ZAWYA-PRESSR: Healthcare leaders call for greater strategic alignment between capital investment and health system strategy at WHX | Global healthcare leaders gathered at the World Health Expo (WHX) to discuss the need for strategic alignment between ca | [Link](https://longbridge.com/zh-CN/news/275449733.md) | | Where Were The Job Opportunities In 2025? Where Will They Be In 2026? | In 2025, job growth was minimal, with only Education and Health Care (+697,000 jobs) and Leisure and Hospitality (+119,0 | [Link](https://longbridge.com/zh-CN/news/275986113.md) | --- > **免责声明**:本文内容仅供参考,不构成任何投资建议。